Staging and treatment of oropharyngeal cancer in the human papillomavirus era

Oropharyngeal squamous cell carcinoma (SCC) is staged using the TNM system. Human papillomavirus (HPV)‐positive tumors have improved prognosis, despite presenting at advanced stage. Optimal treatment and stratification of HPV‐positive patients are not clearly defined.

[1]  A. Giuliano,et al.  Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C. , 2009, Head & neck.

[2]  D. Elashoff,et al.  Histopathologic findings of HPV and p16 positive HNSCC , 2010, The Laryngoscope.

[3]  R. Shaw,et al.  Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. , 2010, Oral oncology.

[4]  A. Giuliano,et al.  HEAD AND NECK SQUAMOUS CELL CANCER AND THE HUMAN PAPILLOMAVIRUS: SUMMARY OF A NATIONAL CANCER INSTITUTE STATE OF THE SCIENCE MEETING, , 2009 .

[5]  L. Terracciano,et al.  Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? , 2009, International journal of cancer.

[6]  B. Rose,et al.  Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy , 2010, British Journal of Cancer.

[7]  L. Mariani,et al.  High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  E. Speel,et al.  Marked differences in survival rate between smokers and nonsmokers with HPV 16‐associated tonsillar carcinomas , 2008, International journal of cancer.

[9]  R. Laborde,et al.  Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. , 2012, Mayo Clinic proceedings.

[10]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[11]  L. Terracciano,et al.  p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[13]  K. Ang,et al.  Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  E. Sturgis,et al.  Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. , 2012, Seminars in radiation oncology.

[15]  K. Ang,et al.  Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  S. Taylor.  Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.

[17]  F. Spijkervet,et al.  Swallowing dysfunction in cancer patients , 2011, Supportive Care in Cancer.

[18]  B. Haughey,et al.  Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced‐stage oropharyngeal cancer , 2011, The Laryngoscope.

[19]  R. Seethala.  Current State of Neck Dissection in the United States , 2009, Head and neck pathology.

[20]  C. Moskaluk,et al.  Clinical Nodal Staging of T1-2 Tonsillar Squamous Cell Carcinoma Stratified by p16 Status and Implications for Ipsilateral Neck Irradiation , 2010, Cancer journal.

[21]  E. Speel,et al.  Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas , 2009, The Laryngoscope.

[22]  J. Califano,et al.  Cystic lymph node metastasis in patients with head and neck cancer: An HPV‐associated phenomenon , 2008, Head & neck.

[23]  J. Bishop,et al.  Human Papillomavirus-Related Small Cell Carcinoma of the Oropharynx , 2011, The American journal of surgical pathology.

[24]  K. Bjordal,et al.  Quality of Life and Head and Neck Cancer: A 5 Year Prospective Study , 2005, The Laryngoscope.

[25]  Jens Overgaard,et al.  Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  B. Rose,et al.  Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  Zhe Zhang,et al.  Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas , 2009, The Laryngoscope.

[28]  J. Betka,et al.  HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer , 2008, European Archives of Oto-Rhino-Laryngology.

[29]  J. Salassa.  A Functional Outcome Swallowing Scale for Staging Oropharyngeal Dysphagia , 2000, Digestive Diseases.

[30]  E. Vokes,et al.  Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.